The content of our website has been compiled with meticulous care and to the best of our knowledge. However, we cannot assume any liability for the up-to-dateness, completeness or accuracy of any of the pages.
Pursuant to section 7, para. 1 of the TMG (Telemediengesetz – Tele Media Act by German law), we as service providers are liable for our own content on these pages in accordance with general laws. However, pursuant to sections 8 to 10 of the TMG, we as service providers are not under obligation to monitor external information provided or stored on our website. Once we have become aware of a specific infringement of the law, we will immediately remove the content in question. Any liability concerning this matter can only be assumed from the point in time at which the infringement becomes known to us.
Our website contains links to the websites of third parties („external links“). As the content of these websites is not under our control, we cannot assume any liability for such external content. In all cases, the provider of information of the linked websites is liable for the content and accuracy of the information provided. At the point in time when the links were placed, no infringements of the law were recognisable to us. As soon as an infringement of the law becomes known to us, we will immediately remove the link in question.
The content and works published on this website are governed by the copyright laws of Germany. Any duplication, processing, distribution or any form of utilisation beyond the scope of copyright law shall require the prior written consent of the author or authors in question.
A visit to our website can result in the storage on our server of information about the access (date, time, page accessed). This does not represent any analysis of personal data (e.g., name, address or e-mail address). If personal data are collected, this only occurs – to the extent possible – with the prior consent of the user of the website. Any forwarding of the data to third parties without the express consent of the user shall not take place.
We would like to expressly point out that the transmission of data via the Internet (e.g., by e-mail) can offer security vulnerabilities. It is therefore impossible to safeguard the data completely against access by third parties. We cannot assume any liability for damages arising as a result of such security vulnerabilities.
The use by third parties of all published contact details for the purpose of advertising is expressly excluded. We reserve the right to take legal steps in the case of the unsolicited sending of advertising information; e.g., by means of spam mail.
The following text contains information regarding the methods of preventing illness and selfcare while coping with it. It is to be used responsibly. The following procedures cannot supplement professional medical treatment and healing in case of health issues.
The text is not to be reproduced in any way without the written consent of the authors.
FOREWORD
With the beginning of the new millennium, mankind has entered a realm ruled by stress, anxiety and other similar issues yet unknown to the human mind. These issues, often tied to the overwhelming amount of information we tend to receive daily, leave consequences both on our nervous and immune systems. Despite the amazing medical breakthroughs of the past century, we simply cannot function without nature. Nature is the only constant presence in our lives and since we are born from it, it is only fair to at least try to acquire a certain amount of knowledge about its secrets.
Cannabis is perhaps the most perfect example of man’s dependence on nature; throughout history (leaving out the last two unfortunate centuries, when the prohibition of cannabis creates an ever-greater gap between man and nature), it has provided him with just about everything – it was the key ingredient of clothes, ropes, food, medicine, paper and other necessities of everyday life.
Due to the massive amount of unreliable information on cannabis circling the wide web, we wish to gather some key facts on its effect on human life, which can become more centered and relaxed with its prudent use.
SOURCES:
Abrahamov A., Mechoulam R, An efficient new cannabinoid antiemetic in pediatric oncology, Life sci., 1995, 56, pp. 23-24.
Abrams DI., Guzman M., Can cannabis cure cancer?, JAMA Oncol. 2020, pp. 323-324.
Abrams DI., Guzman M., Cannabis in cancer care, Clin. Pharmacol. Ther. 2015, 97, pp. 575-86.
Ahmed A., van der Marck MA., van der ELSEN G., Cannabinoids in late – onset Alzheimer’s disease, Clin. Pharmacol. Ther. 2015, 97, pp. 597-606.
Andre CM., Hausman JF., Guerriero G., Cannabis sativa: the plant of the thousand and one molecules, Front Plant Sci., 2016, 7.
Appendino G., Gibbons S., Gianna A., Pagani A., Grassi G., Stavri M., Smith E., Antibacterial cannabinoids from Cannabis sativa: a structure-activity study, J. Nat Prod., 2008, 71, pp. 1427-30.
Ar K., Bhatnagar S, Use of cannabis and cannabinoids in palliative care setting, Curr. Opin. Anaesthesiol 2020, 33, pp. 841-46.
Gates, P., Copeland, J., Swift, W., & Martin, G. (2012). Barriers and facilitators to cannabis treatment. Drug and alcohol review, 31(3), 311-319.
Martín-Sánchez, E., Furukawa, T. A., Taylor, J., & Martin, J. L. R. (2009). Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain medicine, 10(8), 1353-1368.
Rooke, S., Copeland, J., Norberg, M., Hine, D., & McCambridge, J. (2013). Effectiveness of a self-guided web-based cannabis treatment program: randomized controlled trial. Journal of medical Internet research, 15(2), e26.
Turna, J., Patterson, B., & Van Ameringen, M. (2017). Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?. Depression and anxiety, 34(11), 1006-1017.
Schleider, L. B. L., Mechoulam, R., Saban, N., Meiri, G., & Novack, V. (2019). Real life experience of medical cannabis treatment in autism: analysis of safety and efficacy. Scientific reports, 9(1), 1-7.
Li, X., Vigil, J. M., Stith, S. S., Brockelman, F., Keeling, K., & Hall, B. (2019). The effectiveness of self-directed medical cannabis treatment for pain. Complementary therapies in medicine, 46, 123-130.
Nordstrom, B. R., & Levin, F. R. (2007). Treatment of cannabis use disorders: a review of the literature. The American journal on addictions, 16(5), 331-342.
Lahat, A., Lang, A., & Ben-Horin, S. (2012). Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study. Digestion, 85(1), 1-8.
Marlatt, G. A. (2006). Cannabis dependence: its nature, consequences and treatment. Cambridge university press.
Stiglick, A., & Kalant, H. (1985). Residual effects of chronic cannabis treatment on behavior in mature rats. Psychopharmacology, 85(4), 436-439.
Savage, S. R., Romero-Sandoval, A., Schatman, M., Wallace, M., Fanciullo, G., McCarberg, B., & Ware, M. (2016). Cannabis in pain treatment: clinical and research considerations. The Journal of Pain, 17(6), 654-668.
Solowij, N., Stephens, R. S., Roffman, R. A., Babor, T., Kadden, R., Miller, M., … & Marijuana Treatment Project Research Group. (2002). Cognitive functioning of long-term heavy cannabis users seeking treatment. Jama, 287(9), 1123-1131.
Lintzeris, N., Bhardwaj, A., Mills, L., Dunlop, A., Copeland, J., McGregor, I., … & Allsop, D. (2019). Nabiximols for the treatment of cannabis dependence: a randomized clinical trial. JAMA internal medicine, 179(9), 1242-1253.
Dennis, M., Godley, S. H., Diamond, G., Tims, F. M., Babor, T., Donaldson, J., … & Funk, R. (2004). The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. Journal of substance abuse treatment, 27(3), 197-213.
Naftali, T., Lev, L. B., Yablecovitch, D., Half, E., & Konikoff, F. M. (2011). Treatment of Crohn’s disease with cannabis: an observational study. The Israel Medical Association journal: IMAJ, 13(8), 455-458.
Copersino, M. L., Boyd, S. J., Tashkin, D. P., Huestis, M. A., Heishman, S. J., Dermand, J. C., … & Gorelick, D. A. (2006). Cannabis withdrawal among non‐treatment‐seeking adult cannabis users. The American Journal on Addictions, 15(1), 8-14.
M Weinstein, A., & A Gorelick, D. (2011). Pharmacological treatment of cannabis dependence. Current pharmaceutical design, 17(14), 1351-1358.
Gaston, T. E., & Szaflarski, J. P. (2018). Cannabis for the treatment of epilepsy: an update. Current neurology and neuroscience reports, 18(11), 1-9.
Abuhasira, R., Schleider, L. B. L., Mechoulam, R., & Novack, V. (2018). Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European journal of internal medicine, 49, 44-50.
Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2018). Cannabis for the treatment of Crohn’s disease. Cochrane Database of Systematic Reviews, (11).
Habib, G., & Artul, S. (2018). Medical cannabis for the treatment of fibromyalgia. JCR: Journal of Clinical Rheumatology, 24(5), 255-258.
Scherma, M., Masia, P., Deidda, M., Fratta, W., Tanda, G., & Fadda, P. (2018). New perspectives on the use of cannabis in the treatment of psychiatric disorders. Medicines, 5(4), 107.
Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2018). Cannabis for the treatment of ulcerative colitis. Cochrane Database of Systematic Reviews, (11).
Lucas, P. (2012). Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain. Journal of psychoactive drugs, 44(2), 125-133.
Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., … & Pogarell, O. (2019). How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review. European archives of psychiatry and clinical neuroscience, 269(1), 87-105.
MacCallum, C. A., & Russo, E. B. (2018). Practical considerations in medical cannabis administration and dosing. European journal of internal medicine, 49, 12-19.
Agarwal, R., Burke, S. L., & Maddux, M. (2019). Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. BMC psychiatry, 19(1), 1-10.
Dennis, M., Titus, J. C., Diamond, G., Donaldson, J., Godley, S. H., Tims, F. M., … & CYT Steering Committee. (2002). The Cannabis Youth Treatment (CYT) experiment: rationale, study design and analysis plans. Addiction, 97, 16-34.
Blake, D. R., Robson, P., Ho, M., Jubb, R. W., & McCabe, C. S. (2006). Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology, 45(1), 50-52.
Copeland, J., & Maxwell, J. C. (2007). Cannabis treatment outcomes among legally coerced and non-coerced adults. BMC Public Health, 7(1), 1-7.
Russo, E. (1998). Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. Pain, 76(1-2), 3-8.
Campbell, G., Stockings, E., & Nielsen, S. (2019). Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. European archives of psychiatry and clinical neuroscience, 269(1), 135-144.
Miller, R. J., & Miller, R. E. (2017). Is cannabis an effective treatment for joint pain. Clin Exp Rheumatol, 35(5), 59-67.
Press, C. A., Knupp, K. G., & Chapman, K. E. (2015). Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy & Behavior, 45, 49-52.
Haroutounian, S., Ratz, Y., Ginosar, Y., Furmanov, K., Saifi, F., Meidan, R., & Davidson, E. (2016). The effect of medicinal cannabis on pain and quality-of-life outcomes in chronic pain. The Clinical journal of pain, 32(12), 1036-1043.
Russo, E. B. (2017). Cannabis and epilepsy: an ancient treatment returns to the fore. Epilepsy & Behavior, 70, 292-297.
Porter, B. E., & Jacobson, C. (2013). Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy & Behavior, 29(3), 574-577.
Aggarwal, S. K., Carter, G. T., Sullivan, M. D., ZumBrunnen, C., Morrill, R., & Mayer, J. D. (2009). Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State. Journal of Opioid Management, 5(5), 257-286.
Mechoulam, R. (2012, February). Cannabis—a valuable drug that deserves better treatment. In Mayo Clinic Proceedings (Vol. 87, No. 2, pp. 107-109). Elsevier.
Hausman-Kedem, M., Menascu, S., & Kramer, U. (2018). Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents–An observational, longitudinal study. Brain and Development, 40(7), 544-551.
Lakhan, S. E., & Rowland, M. (2009). Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC neurology, 9(1), 1-6.
Berman, P., Sulimani, L., Gelfand, A., Amsalem, K., Lewitus, G. M., & Meiri, D. (2020). Cannabinoidomics–An analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolome. Talanta, 219, 121336.
Babson, K. A., & Bonn-Miller, M. O. (2014). Sleep disturbances: Implications for cannabis use, cannabis use cessation, and cannabis use treatment. Current Addiction Reports, 1(2), 109-114.
Schleider, L. B. L., Mechoulam, R., Lederman, V., Hilou, M., Lencovsky, O., Betzalel, O., … & Novack, V. (2018). Prospective analysis of safety and efficacy of medical cannabis in large, unselected population of patients with cancer. European journal of internal medicine, 49, 37-43.
